AbCellera to Participate at Upcoming Investor Conferences in November and December 2025 Biotech Investing
Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion Life Science Investing
Galectin Therapeutics to Present at the American Association for the Study of Liver Disease Liver Meeting 2025 Life Science Investing
Nautilus Biotechnology to Announce Third Quarter 2025 Financial Results on October 28, 2025 Biotech Investing
Arrowhead Pharmaceuticals Files CTA for Investigational ARO-DIMER-PA - the First Dual Functional RNAi Therapeutic for the Treatment of Mixed Hyperlipidemia Biotech Investing
